IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $825,000 | -19.8% | 86,118 | -7.6% | 0.01% | -20.0% |
Q2 2022 | $1,029,000 | -61.7% | 93,236 | -42.3% | 0.01% | -65.5% |
Q1 2022 | $2,689,000 | -21.5% | 161,528 | -10.0% | 0.03% | -25.6% |
Q4 2021 | $3,425,000 | -26.9% | 179,419 | -5.6% | 0.04% | -13.3% |
Q3 2021 | $4,686,000 | -10.1% | 190,019 | -5.2% | 0.04% | -2.2% |
Q2 2021 | $5,215,000 | – | 200,430 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |